Skip to main content

Lavaca Capital LLC

Position in LLY — ELI LILLY & Co

CIK 1641447 HOUSTON, TX

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$582,923
+$227,892 QoQ
Shares Held
486
+25.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#3,620
of 4,605 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2022
CallValue
$0
CallShares
0
PutValue
$1,102,382
PutShares
3,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Lavaca Capital LLC holds $11,294,866 across 14 Drug Manufacturers - General names. LLY ranks #3 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 LLY
ELI LILLY & Co
This page
486 $582,923

All Filings in LLY

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $582,923 486
2026-03-31 $355,031 386
2025-12-31 $414,826 386
2025-09-30 $295,281 387
2025-06-30 $1,015,727 1,303
2025-03-31 $992,743 1,202
2024-12-31 $968,860 1,255
2024-09-30 $1,063,128 1,200
2024-06-30 $1,085,550 1,199
2024-03-31 $931,996 1,198
2023-12-31 $1,720,779 2,952
2023-09-30 $1,616,761 3,010
2023-06-30 $1,488,542 3,174
2023-03-31 $1,118,862 3,258
2022-12-31 $1,227,393 3,355
2022-09-30 $1,132,695 3,503
2022-06-30 $1,780,346 5,491
2022-06-30 $1,102,382 3,400
2022-03-31 $1,686,146 5,888
2022-03-31 $1,403,213 4,900
2021-12-31 $1,298,234 4,700
2021-12-31 $3,711,291 13,436
2021-09-30 $3,150,135 13,634
2021-09-30 $1,132,145 4,900
2021-06-30 $3,129,046 13,633
2021-06-30 $1,193,504 5,200
2021-03-31 $896,736 4,800
2021-03-31 $1,018,729 5,453
2020-12-31 $474,102 2,808
2020-09-30 $1,139,013 7,695